As more consumers lose weight, demand begins to shift toward smaller sizes
There is substantial preclinical evidence and mounting retrospective and prospective randomized controlled trial evidence that GLP-1RAs could be effective for reducing alcohol consumption
This means it only stimulates insulin when blood glucose levels are elevated, reducing the risk of hypoglycemia
Branded pens (Ozempic, Wegovy, Mounjaro, Zepbound) have fixed dose increments and come with manufacturer-provided escalation schedules
To provide a snapshot of costs for different doses over a one-month supply: Liraglutide 0.6 mg: $450-$600 Liraglutide 1.2 mg: $600-$800 Semaglutide GLP-1 0.5 mg: $900-$1,200 Semaglutide GLP-1 1.0 mg: $1,200-$1,600 Despite Semaglutide GLP-1s higher initial price, its less frequent administration could make it a more cost-effective option for some of our patients over time